Dexamethasone/voriconazoleInvasive aspergillosis following off-label use; lack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1903卷 / 1期

关键词：

D O I：

10.1007/s40278-022-13722-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：160 / 160

相关论文

共 50 条

[21] Dexamethasone/remdesivirNeisseria meningitidis pneumonia, lack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1938 (1) : 513 - 513
[22] Dexamethasone/diltiazem/remdesivirBradycardia, cardiotoxicity, lack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1969 (1) : 146 - 146
[23] DexamethasonePulmonary aspergillosis following off-label use: case report
Reactions Weekly, 2022, 1934 (1) : 166 - 166
[24] Doxorubicin/lenvatinibNausea following off-label use and lack of efficacy: case report
Reactions Weekly, 2023, 1946 (1) : 208 - 208
[25] Corticosteroids/methotrexateDiabetes and lack of efficacy following off-label use: case report
Reactions Weekly, 2023, 1942 (1) : 95 - 95
[26] AntineoplasticsVarious toxicities following off-label use and lack of efficacy : case report
Reactions Weekly, 2022, 1913 (1) : 70 - 70
[27] Multiple drugsDizziness following off-label use; lack of efficacy: case report
Reactions Weekly, 2021, 1860 (1) : 244 - 244
[28] AntineoplasticsProlonged neutropenia following off-label use and lack of efficacy: case report
Reactions Weekly, 2024, 2031 (1) : 42 - 42
[29] Multiple drugsNausea following off-label use and lack of efficacy: case report
Reactions Weekly, 2022, 1924 (1) : 327 - 327
[30] Dexamethasone/voriconazoleInvasive cerebral aspergillosis due to Aspergillus Niger, lack of efficacy, off label use and medication error: 3 case reports
Reactions Weekly, 2023, 1976 (1) : 131 - 131

← 1 2 3 4 5 →